Search Results

Postmarket Data Support Cook's Zenith t-Branch Endograft to Treat TAAA

April 17, 2019—An off-the-shelf endograft (Zenith t-Branch, Cook Medical) for the treatment of thoracoabdominal aortic aneurysm (TAAA) provides a safe and straightforward solution for a wide range of patients—including emergency cases—according to findings presented by Martin Austermann, MD, at the Charing Cross Symposium, held April 15–18 in London, United Kingdom.

Gore's TAG Conformable Thoracic Stent Graft With Active Control System Approved in Europe

July 13, 2017—Gore & Associates announced the first patient implant of its TAG conformable thoracic stent graft with Active Control System, which received European CE Mark approval in June for thoracic endovascular aortic repair (TEVAR).

SOCRATES Study Begins in Germany to Compare ESAR and FEVAR Treatments of AAA

June 15, 2021—St. Franziskus-Hospital in Münster, Germany, announced the commencement of the postmarket SOCRATES study comparing endosuture aneurysm repair (ESAR) to fenestrated endovascular aneurysm repair (FEVAR) in patients with hostile infrarenal neck abdominal aortic aneurysms (AAAs).

Bentley BeGraft Peripheral Plus Stent Evaluated as Bridging Stent in BEVAR Procedures

March 10, 2023—Bentley InnoMed GmbH announced that recruitment has been completed in a clinical study evaluating the safety and performance of the company’s BeGraft Peripheral Plus (BGP+) expandable covered stent as a bridging stent in branched endovascular aortic repair (BEVAR) procedures.

European Postmarket Registry Begins for Gore's TAG Conformable Thoracic Stent Graft With Active Control System

November 2, 2017—Gore & Associates recently announced the first enrollment in its postmarket European SURPASS registry for its TAG conformable thoracic stent graft with Active Control system.

Bentley’s BeGraft Plus for BEVAR Receives CE Mark Approval

November 19, 2025—Bentley InnoMed GmbH announced CE Mark approval for the company’s BeGraft Plus for use as a bridging stent graft in branched endovascular aneurysm repair (BEVAR), expanding Bentley’s portfolio for complex aortic interventions.

First Patient Recruited in Trial to Obtain Indication for Bentley BeGraft Peripheral Plus in BEVAR

September 21, 2020—Bentley announced the recruitment of the first patient into a trial investigating the company’s BeGraft Peripheral Plus stent graft system as a bridging stent in branched endovascular aortic repair (BEVAR) for the treatment of complex aortic aneurysms.